Emerging role of RNA methyltransferase METTL3 in gastrointestinal cancer

被引：0
作者：
Qiang Wang
Wei Geng
Huimin Guo
Zhangding Wang
Kaiyue Xu
Chen Chen
Shouyu Wang
机构：
[1] The Affiliated Drum Tower Hospital of Nanjing University Medical School,Department of Hepatobiliary Surgery
[2] The Affiliated Yancheng No. 1 People’s Hospital of Nanjing University Medical School,Department of Gastroenterology
[3] The Affiliated Drum Tower Hospital of Nanjing University Medical School,Department of Radiotherapy
[4] The First Affiliated Hospital of Nanjing Medical University,Department of Molecular Cell Biology and Toxicology, Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health
[5] Nanjing Medical University,Jiangsu Key Laboratory of Molecular Medicine
[6] Medical School of Nanjing University,Center for Public Health Research
[7] Medical School of Nanjing University,undefined
来源：
Journal of Hematology & Oncology | / 13卷
关键词：
Gastrointestinal cancer; Epigenetics; METTL3; Oncogene; m; A;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Gastrointestinal cancer, the most common solid tumor, has a poor prognosis. With the development of high-throughput sequencing and detection technology, recent studies have suggested that many chemical modifications of human RNA are involved in the development of human diseases, including cancer. m6A, the most abundant modification, was revealed to participate in a series of aspects of cancer progression. Recent evidence has shown that methyltransferase-like 3 (METTL3), the first identified and a critical methyltransferase, catalyzes m6A methylation on mRNA or non-coding RNA in mammals, affecting RNA metabolism. Abnormal m6A levels caused by METTL3 have been reported to be involved in different aspects of cancer development, including proliferation, apoptosis, and metastasis. In this review, we will shed light on recent findings regarding the biological function of METTL3 in gastrointestinal cancer and discuss future research directions and potential clinical applications of METTL3 for gastrointestinal cancer.
引用
收藏
相关论文
共 325 条
  • [1] Zhou S.(2016)Emergence of the Noncoding Cancer Genome: A Target of Genetic and Epigenetic Alterations Cancer Discovery 6 1215-1229
  • [2] Treloar A. E.(2019)Transgenerational Inheritance of Environmentally Induced Epigenetic Alterations during Mammalian Development Cells 8 1559-536
  • [3] Lupien M.(2019)Genetics and epigenetics of gastroenteropancreatic neuroendocrine neoplasms Endocrine reviews 40 506-1566
  • [4] Legoff Louis(2016)Current challenges in cancer treatment Clinical therapeutics 38 1551-563
  • [5] D’Cruz Shereen Cynthia(2012)Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation Gastroenterology 143 550-109
  • [6] Tevosian Sergei(2020)Epigenetic regulation of epithelial-mesenchymal transition: focusing on hypoxia and TGF-beta signaling Journal of biomedical science 27 39-77
  • [7] Primig Michael(2016)Targeting epigenetic regulations in cancer Acta biochimica et biophysica Sinica 48 97-25
  • [8] Smagulova Fatima(2017)The promise of epigenetic therapy: reprogramming the cancer epigenome Current opinion in genetics & development 42 68-1107
  • [9] Mafficini A(2015)Cancer epigenetics: an introduction Methods in molecular biology 1238 3-42
  • [10] Scarpa A(2017)The chemistries and consequences of DNA and RNA methylation and demethylation RNA biology 14 1099-331
12345678910